Protective Effects of the Carotenoid Zeaxanthin in Experimental Nonalcoholic Steatohepatitis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Digestive Diseases and Sciences

• Publication date

  2009-05-08

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10620-009-0824-2PMID 19424798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

  2008cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• The role of carotenoids in the prevention of human pathologies.

  2004cited by this paper
• Retinoids in cancer chemoprevention.

  2004influential reference
• Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States.

  2003influential reference
• Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis.

  2003cited by this paper
• Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E

  2003cited by this paper
• All- trans (cid:1) -Carotene Appears to Be More Bioavailable than 9- cis or 13- cis (cid:1) -Carotene in Gerbils Given Single Oral Doses of Each Isomer 1,2

  2002cited by this paper
• Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail.

  2002cited by this paper
• All-trans beta-carotene appears to be more bioavailable than 9-cis or 13-cis beta-carotene in gerbils given single oral doses of each isomer.

  2002cited by this paper
• Zeaxanthin dipalmitate from Lycium chinense fruit reduces experimentally induced hepatic fibrosis in rats.

  2002cited by this paper
• Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models.

  2002cited by this paper
• Metformin in non-alcoholic steatohepatitis.

  2001cited by this paper
• Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

  2001cited by this paper
• Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract.

  2001cited by this paper
• Atorvastatin for the treatment of NASH

  2001cited by this paper
• Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density.

  2000cited by this paper
• Review of animal models in carotenoid research.

  1999cited by this paper
• Zeaxanthin dipalmitate from Lycium chinense has hepatoprotective activity.

  1997cited by this paper
• Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

  1996cited by this paper
• Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue.

  1991cited by this paper
• Cytochrome P-450 and oxidative stress

  1990cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper

• Protective role of zeaxanthin on acrylamide-induced neurotoxicity in Wistar rats

  2025cites this paper
• Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced Hepatotoxicity

  2025cites this paper
• High-yield zeaxanthin production in Chlamydomonas reinhardtii via advanced metabolic pathway engineering

  2025cites this paper
• High-Dose β-Carotene Suppresses Non-Alcoholic Steatohepatitis Progression in a Mouse Model.

  2025cites this paper
• Antidotal properties of zeaxanthin as a functional food and one of the most common carotenoids in nature: A review

  2024cites this paper
• Investigating the effect of zeaxanthin on olanzapine-induced metabolic disorders in rats

  2024cites this paper
• Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study

  2024cites this paper
• Optimization of accelerated solvent extraction of zeaxanthin from orange paprika using response surface methodology and an artificial neural network coupled with a genetic algorithm

  2024cites this paper
• Associations of serum carotenoids with all-cause and cardiovascular mortality in adults with MAFLD.

  2024cites this paper
• Insights into the molecular mechanisms of malnutrition‐associated steatohepatitis: A review

  2024cites this paper
• Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study

  2023cites this paper
• Biochemical and Immunological implications of Lutein and Zeaxanthin

  2021cites this paper
• Functional Foods for the Management of Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Zeaxanthin Exhibits Protective Effects in Myocardial Injury by Inhibiting TGF-β/Smad2/3 and p38MAPK/NF-κB Signaling Pathways

  2021cites this paper
• Consumption of Spinach and Tomato Modifies Lipid Metabolism, Reducing Hepatic Steatosis in Rats

  2020cites this paper
• Carotenoids and fatty liver disease: Current knowledge and research gaps.

  2020cites this paper
• Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

  2019cites this paper
• Chapter 5 Role of Dietary Carotenoids in Different Etiologies of Chronic Liver Diseases

  2019cites this paper
• Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and Skin

  2019cites this paper
• Zeaxanthin Dipalmitate in the Treatment of Liver Disease

  2019cites this paper
• Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review

  2019cites this paper
• Siphonaxanthin, a Carotenoid From Green Algae, Inhibits Lipogenesis in Hepatocytes via the Suppression of Liver X Receptor α Activity.

  2018cites this paper
• Role of Dietary Carotenoids in Different Etiologies of Chronic Liver Diseases

  2018cites this paper
• Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats

  2016cites this paper
• The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease

  2016cites this paper
• Zeaxanthin Dipalmitate Therapeutically Improves Hepatic Functions in an Alcoholic Fatty Liver Disease Model through Modulating MAPK Pathway

  2014influential citation
• Protective effect of guabiju (Myrcianthes pungens (O. Berg) D. Legrand) and red guava (Psidium cattleyanum Sabine) against cisplatin-induced hypercholesterolemia in rats

  2014cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIA E TECNOLOGIA DE ALIMENTOS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIA E TECNOLOGIA DE ALIMENTOS

  2012cites this paper
• Cardioprotective Efficacy of a Novel Antioxidant Mix VitaePro Against Ex Vivo Myocardial Ischemia–Reperfusion Injury

  2011cites this paper
• Chemistry, Stability, and Biological Actions of Carotenoids

  2009cites this paper